美国亚专业医疗瘤学家利用癌症护理的地理差异,2008年至2020年
René Karadakic1, Christopher Manz2, Arno Cai1
1Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts (R.K., A.C.).
瘤学家子专业化正在上升,子专家管理更多的癌症护理. 然而,获得这些专家的机会在地区和收入水平之间分布不均,扩大了差距.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 医学经济学 医学经济学
背景情况:
- 癌症护理的复杂性正在增加,这可能会导致医疗瘤学家的分专业化.
- 关于瘤学家子专业化和利用模式的趋势,人们知之甚少.
研究的目的:
- 量化美国瘤学子专业化趋势.
- 评估利用亚专业化癌症护理的差异.
主要方法:
- 使用国家费用服务医疗保险索赔数据 (2007-2021) 的回顾性队列研究.
- 根据单一癌症类型中管理超过80%的化疗发作,确定了子专家.
- 分析了开始治疗的医疗保险受益人 (2008-2020) 的化疗事件.
主要成果:
- 副专家管理的化疗发作的比例从9% (2008) 增加到18% (2020).
- 使用率因癌症类型和地区而异,大都市地区的使用率更高.
- 收入差异扩大:在2020年,最高收入县的发病率为27.6%,最低收入县的发病率为8.8%,由子专家管理.
结论:
- 瘤学子专业化正在增加,但分布不均.
- 在不同地理区域和社会经济群体的分专业利用方面存在显著的差异.
- 越来越多的基于收入的收入差异在获得亚专业化癌症护理方面需要引起注意.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
相关概念视频
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
